Characterisation of cell membrane interaction mechanisms of antimicrobial peptides by electrical bilayer recording

被引:21
作者
Priyadarshini, Diana [1 ]
Ivica, Josip [1 ]
Separovic, Frances [2 ]
de Planque, Maurits R. R. [1 ]
机构
[1] Univ Southampton, Fac Phys & Appl Sci, Elect & Comp Sci, Southampton SO17 1BJ, Hants, England
[2] Univ Melbourne, Sch Chem, Bio21 Inst, Melbourne, Vic 3010, Australia
关键词
Antimicrobial peptides; Bilayer lipid membranes; Lipid-peptide interactions; Phospholipids; AUREIN; 1.2; MELITTIN; ENHANCE; MODEL;
D O I
10.1016/j.bpc.2021.106721
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Many antimicrobial peptides (AMPs) are cationic host defence peptides (HDPs) that interact with microbial membranes. This ability may lead to implementation of AMPs as therapeutics to overcome the wide-spread antibiotic resistance problem as the affected bacteria may not be able to recover from membrane lysis types of attack. AMP interactions with lipid bilayer membranes are typically explained through three mechanisms, i.e., barrel-stave pore, toroidal pore and carpet models. Electrical bilayer recording is a relatively simple and sensitive technique that is able to capture the nanoscale perturbations caused by the AMPs in the bilayer membranes. Molecular-level understanding of the behaviour of AMPs in relation to lipid bilayers mimicking bacterial and human cell membranes is essential for their development as novel therapeutic agents that are capable of targeted action against disease causing micro-organisms. The effects of four AMPs (aurein 1.2, caerin 1.1, citropin 1.1 and maculatin 1.1 from the skin secretions of Australian tree frogs) and the toxin melittin (found in the venom of honeybees) on two different phospholipid membranes were studied using the electrical bilayer recording technique. Bilayers composed of zwitterionic (DPhPC) and anionic (DPhPC/POPG) lipids were used to mimic the charge of eukaryotic and prokaryotic cell membranes, respectively, so as to determine the corresponding interaction mechanisms for different concentrations of the peptide. Analysis of the dataset corresponding to the four frog AMPs, as well as the resulting dataset corresponding to the bee toxin, confirms the proposed peptidebilayer interaction models in existing publications and demonstrates the importance of using appropriate bilayer compositions and peptide concentrations for AMP studies.
引用
收藏
页数:7
相关论文
共 45 条
  • [1] Direct visualization of membrane leakage induced by the antibiotic peptides: Maculatin, citropin, and aurein
    Ambroggio, EE
    Separovic, F
    Bowie, JH
    Fidelio, GD
    Bagatolli, LA
    [J]. BIOPHYSICAL JOURNAL, 2005, 89 (03) : 1874 - 1881
  • [2] [Anonymous], 2018, BC 535 MAN 060126
  • [3] [Anonymous], 2012, AX GUID EL BIOPH LAB, V3rd
  • [4] [Anonymous], 2018, INTR BLM WORKST
  • [5] Aquila M., 2012, PATCH CLAMP TECHNIQU, P332
  • [6] The antimicrobial peptide gramicidin S permeabilizes phospholipid bilayer membranes without forming discrete ion channels
    Ashrafuzzaman, Md.
    Andersen, O. S.
    McElhaney, R. N.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2008, 1778 (12): : 2814 - 2822
  • [7] Formation and characterization of planar lipid bilayer membranes from synthetic phytanyl-chained glycolipids
    Baba, T
    Toshima, Y
    Minamikawa, H
    Hato, M
    Suzuki, K
    Kamo, N
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1421 (01): : 91 - 102
  • [8] A coarse-grained approach to studying the interactions of the antimicrobial peptides aurein 1.2 and maculatin 1.1 with POPG/POPE lipid mixtures
    Balatti, G. E.
    Martini, M. F.
    Pickholz, M.
    [J]. JOURNAL OF MOLECULAR MODELING, 2018, 24 (08)
  • [9] Horizontal Bilayer for Electrical and Optical Recordings
    Bartsch, Philipp
    Walter, Claudius
    Selenschik, Philipp
    Honigmann, Alf
    Wagner, Richard
    [J]. MATERIALS, 2012, 5 (12) : 2705 - 2730
  • [10] Mode-of-Action of Antimicrobial Peptides: Membrane Disruption vs. Intracellular Mechanisms
    Benfield, Aurelie H.
    Henriques, Sonia Troeira
    [J]. FRONTIERS IN MEDICAL TECHNOLOGY, 2020, 2